Table 1.
Age (years) | BMI (kg/m2) | FSH (IU/mL) | LH (IU/mL) | AMH (ng/mL) | TSH (mIU/L) | PRL (ng/mL) | ||
---|---|---|---|---|---|---|---|---|
Rotterdam | PCOS | 27.4 ± 5.4 | 25.5 ± 4.6 | 4.9 ± 1.6a | 6.1 ± 4.3a | 8.6 ± 6.5a | 1.7 ± 0.9 | 18.7 ± 8.5a |
Non-PCOS | 31.2 ± 4.9 | 26.3 ± 6.4 | 7.1 ± 3.1a | 3.8 ± 1.6a | 2.3 ± 1.6a | 1.8 ± 0.9 | 17.9 ± 7.3a | |
Androgen Excess Society | PCOS | 27.1 ± 4.9 | 25.7 ± 4.6 | 4.9 ± 1.6a | 5.9 ± 4.3a | 8.8 ± 6.7a | 1.8 ± 0.8 | 19.1 ± 8.7a |
Non-PCOS | 31.1 ± 5.1 | 26.2 ± 7.5 | 7.1 ± 3.1a | 4.0 ± 2.1a | 2.6 ± 2.3a | 1.8 ± 0.9 | 16.8 ± 7.9a | |
National Institutes of Health | PCOS | 26.2 ± 5.2 | 25.9 ± 4.6 | 4.8 ± 1.6a | 5.9 ± 4.2a | 9.2 ± 7.1a | 1.7 ± 0.9 | 19.6 ± 8.9a |
Non-PCOS | 30.1 ± 5.1 | 26.1 ± 6.9 | 6.9 ± 3.1a | 4.1 ± 2.3a | 2.8 ± 2.6a | 1.8 ± 0.9 | 16.8 ± 7.8a |
Bonferroni test for multiple comparison
aSignificant (p <0.05) within each evaluation system